We are investigating a new treatment for patients with advanced solid tumors to see how safe it is and how well it works. This study will help us understand its effects on tumor growth.
Health conditions and diseases that the clinical trial is designed to study and treat.
This condition refers to advanced or metastatic solid tumors that have a specific genetic alteration known as methylthioadenosine phosphorylase (MTAP) homozygous deletion, which can affect treatment options and prognosis.
Non-Small Cell Lung Cancer (NSCLC) is a type of lung cancer that is characterized by the uncontrolled growth of abnormal cells in the lungs, often leading to symptoms like coughing, chest pain, and difficulty breathing.
Cholangiocarcinoma is a rare cancer that forms in the bile ducts, which can cause symptoms such as jaundice, abdominal pain, and weight loss.
Ductal adenocarcinoma of the pancreas is a common type of pancreatic cancer that can lead to symptoms like abdominal pain, jaundice, and weight loss.
Glioma is a type of tumor that occurs in the brain and spinal cord, arising from glial cells, and can cause symptoms such as headaches, seizures, and cognitive changes.
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.
